Global /China /Healthcare /Medical Devices /688606

Hangzhou Alltest Biotech Co., Ltd.

688606

• SSE: 688606 • Delayed

54.01CNY -1.4%

7.98 USD

As of 14 June 2026, Hangzhou Alltest Biotech Co., Ltd. has a market cap of $625.32M USD, ranking #13671 globally and #4165 in China. It ranks #1227 in the Healthcare sector, and #247 in the Medical Devices industry.

Global Rank

13671

Country Rank

4165

Sector Rank

1227

Industry Rank

247

Key Stats

Market Cap

$625.32MUSD

4.24B CNY

Enterprise Value

$296.67MUSD

2.01B CNY

Revenue (TTM)

$132.56MUSD

898.2M CNY

Net Income (TTM)

$26.04MUSD

176.46M CNY

Profit Margin

20%

PE Ratio

24.7

PS Ratio

4.7

PB Ratio

1.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Fei Gao open_in_new

Employees

960

Founded

2009

Website

alltests.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	-4.3%	-13%	-21%	-20%	-14%	-16%	-10%	-54%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688606 杭州奥泰生物技术股份有限公司 Class A ISIN: CNE1000053G6 Shares Out.: Shares Outstanding: 77.377M¹ Shares Float: 77.37M² TV: TradingView: SSE: 688606 SA: Stock Analysis: SHA: 688606 YF: Yahoo Finance: 688606.SS GF: Google Finance: SHA: 688606 BA: Barron's: 688606 MS: Morningstar: XSHG: 688606	54.01 CNY	TV: TradingView: SSE: 688606 SA: Stock Analysis: SHA: 688606 YF: Yahoo Finance: 688606.SS GF: Google Finance: SHA: 688606 BA: Barron's: 688606 MS: Morningstar: XSHG: 688606

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hangzhou Alltest Biotech Co., Ltd.

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 5K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 797%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 783%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 706%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 628%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 28K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 26K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 25K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 20K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 19K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 16K%	22.2	Ireland

chevron_leftBack